Endotoxin pretreatment inhibits neutrophil proliferation and function

Area of Science:

• Immunology
• Gastroenterology
• Pulmonology

Background:

• Gut ischemia/reperfusion (I/R) injury is known to induce lung injury, involving neutrophils (PMNs).
• Lipopolysaccharide (LPS) administration post-gut I/R exacerbates lung injury, while pretreatment with LPS confers protection.
• The protective mechanism of LPS pretreatment against gut I/R-induced lung injury remains unclear.

Purpose of the Study:

• To investigate whether LPS pretreatment alters the neutrophil inflammatory response in gut I/R injury.
• To determine the effects of LPS pretreatment on neutrophil stem cell proliferation.
• To assess LPS pretreatment's impact on gut I/R-induced neutrophil priming and lung sequestration.

Main Methods:

• Quantified granulocyte-macrophage colony-forming units (CFU-GM) from bone marrow of normal and LPS-pretreated rats.
• Induced gut I/R in rats (45 min superior mesenteric artery occlusion/6 hr reperfusion).
• Assessed in vivo neutrophil priming by measuring superoxide production and quantified lung myeloperoxidase (MPO) for PMN sequestration.

Main Results:

• LPS pretreatment did not significantly alter PMN stem cell proliferation (CFU-GM).
• Gut I/R induced significant PMN priming and lung sequestration in control rats.
• LPS pretreatment significantly reduced gut I/R-induced PMN priming and lung sequestration.

Conclusions:

• LPS pretreatment protects against gut I/R-induced lung injury by mitigating neutrophil activation and lung recruitment.
• The protective effect is not mediated by changes in neutrophil stem cell proliferation.
• LPS pretreatment modulates the inflammatory response of neutrophils during gut I/R.